Entry Detail



General Information

Database ID:exR0089662
RNA Name:hsa-miR-27a-3p
RNA Type:miRNA
Chromosome:chr19
Starnd:-
Coordinate:
Start Site(bp):13836447End Site(bp):13836467
External Links:hsa-miR-27a-3p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
IGF2BP3
chr7
23310209
23470491
-
SOX11
chr2
5692384
5701385
+
AEN
chr15
88621337
88632281
+
SUCO
chr1
172532349
172611833
+
ALDH3A2
chr17
19648136
19685760
+
CD2AP
chr6
47477789
47627263
+
TTYH3
chr7
2631986
2664802
+
C1orf116
chr1
207018522
207032756
-
GLTP
chr12
109850945
109880541
-
PAX9
chr14
36657568
36679362
+
TMEM30A
chr6
75252924
75284948
-
NUAK1
chr12
106063340
106140033
-
LGALS8
chr1
236518000
236552981
+
ACER3
chr11
76860867
77026797
+
NEK2
chr1
211658657
211675630
-
CDR2
chr16
22345936
22437165
-
B4GALT3
chr1
161171310
161177968
-
JRK
chr8
142657460
142681968
-
KCNK1
chr1
233614106
233672514
+
ACLY
chr17
41866917
41930542
-
TMX4
chr20
7977346
8019805
-
PPP1CC
chr12
110719680
110742939
-
KPNA6
chr1
32108056
32176563
+
HTT
chr4
3041422
3243960
+
NF1
chr17
31094927
31382116
+
ETNK1
chr12
22625075
22690665
+
ZBTB34
chr9
126860665
126885878
+
CANX
chr5
179678628
179731641
+
PAK1
chr11
77321707
77474635
-
GIPC1
chr19
14477760
14496149
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000384
chr12
27867712
27877119
+
hsa_circ_0001247
chr22
46125304
46136418
+
hsa_circ_0000942
chr19
46020920
46021352
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010980.2
chr2
222317242
222318653
-
AC021092.1
chr19
44103007
44113183
-
AC022150.4
chr19
52650437
52653284
-
AC093010.3
chr3
114314501
114329714
-
AL050341.2
chr1
40256427
40257967
-
KCNQ1OT1
chr11
2608328
2699994
-
LINC01089
chr12
121795267
121803906
-
LINC02381
chr12
54126082
54147485
+
NEAT1
chr11
65422774
65445540
+
SDCBP2-AS1
chr20
1325405
1378735
+
SNHG22
chr18
49814023
49851059
+
TUG1
chr22
30969245
30979395
+
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.